Literature DB >> 20497765

Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.

Sébastien D S Pion1, Lise Grout, Joseph Kamgno, Hugues Nana-Djeunga, Michel Boussinesq.   

Abstract

Reduction in Onchocerca volvulus skin microfilarial densities after treatment with ivermectin shows wide between-host variation. Data from two separate studies conducted in Cameroon on onchocerciasis patients treated for the first time with ivermectin were analyzed to identify host factors associated with microfilarial density at different time-points after treatment. In one site (Nkam valley), the dataset included 103 adult males for whom age, number of palpable onchocercal nodules and microfilarial densities on D0 (pre-treatment), D15, D80 and D180 were available. In the other site (Vina valley), analyses were conducted on 965 individuals of both sexes aged 5 years and over; in this dataset, available information included age, gender, exact dose of ivermectin received, onchocerciasis endemicity level in the village of residence and microfilarial densities on D0 and D180. Negative binomial regression models of microfilarial density at the different intervals post-treatment were fitted, using maximum likelihood, with the available independent variables. Gender and age were found to be associated with microfilarial density on D180. The initial microfilarial density influenced post-treatment densities at all the time-points. All other things being equal, microfilarial densities on D180 were higher in individuals harbouring a higher number of nodules or living in communities with high endemicity levels. This study demonstrates that O. volvulus microfilarial density measured after a first treatment with ivermectin, and thus probably the rate of skin repopulation by microfilariae (mf) varies according to several host factors. Should such factors also influence ivermectin efficacy after repeated treatment, then they should be taken into account to determine whether sub-optimal responses to treatment reported from various areas in Africa are actually due to parasite-related factors, particularly to the emergence of resistant populations.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497765     DOI: 10.1016/j.actatropica.2010.05.004

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  9 in total

1.  Arbonematodes - nematode infections transmissible by arthropods: arbeitskreis blut, untergruppe «bewertung blutassoziierter krankheitserreger»*.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-01-07       Impact factor: 3.747

2.  Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.

Authors:  Yannick Niamsi-Emalio; Hugues C Nana-Djeunga; Cédric B Chesnais; Sébastien D S Pion; Jules B Tchatchueng-Mbougua; Michel Boussinesq; María-Gloria Basáñez; Joseph Kamgno
Journal:  Clin Infect Dis       Date:  2021-06-14       Impact factor: 9.079

3.  Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.

Authors:  Hugues C Nana-Djeunga; Catherine Bourguinat; Sébastien D Pion; Jean Bopda; Jonas A Kengne-Ouafo; Flobert Njiokou; Roger K Prichard; Samuel Wanji; Joseph Kamgno; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

4.  Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity.

Authors:  Stephen R Doyle; Catherine Bourguinat; Hugues C Nana-Djeunga; Jonas A Kengne-Ouafo; Sébastien D S Pion; Jean Bopda; Joseph Kamgno; Samuel Wanji; Hua Che; Annette C Kuesel; Martin Walker; Maria-Gloria Basáñez; Daniel A Boakye; Mike Y Osei-Atweneboana; Michel Boussinesq; Roger K Prichard; Warwick N Grant
Journal:  PLoS Negl Trop Dis       Date:  2017-07-26

5.  Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.

Authors:  Hudu O Osue
Journal:  Ethiop J Health Sci       Date:  2017-03

Review 6.  Onchocerciasis drug development: from preclinical models to humans.

Authors:  Adela Ngwewondo; Ivan Scandale; Sabine Specht
Journal:  Parasitol Res       Date:  2021-10-13       Impact factor: 2.289

7.  Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.

Authors:  Didier Bakajika; Eric M Kanza; Nicholas O Opoku; Hayford M Howard; Germain L Mambandu; Amos Nyathirombo; Maurice M Nigo; Kambale Kasonia Kennedy; Safari L Masembe; Mupenzi Mumbere; Kambale Kataliko; Kpehe M Bolay; Simon K Attah; George Olipoh; Sampson Asare; Michel Vaillant; Christine M Halleux; Annette C Kuesel
Journal:  PLoS Negl Trop Dis       Date:  2022-04-27

8.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

Review 9.  Research for new drugs for elimination of onchocerciasis in Africa.

Authors:  Annette C Kuesel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-05-19       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.